Magnetic resonance spectroscopy at term-equivalent age in extremely preterm infants: association with cognitive and

Roopali Bapat1, Ponnada A Narayana2, Yuxiang Zhou2

  • 1Division of Neonatology, Department of Pediatrics, Nationwide Children's Hospital and The Department of Pediatrics, The Ohio State University College of Medicine, Columbus, Ohio.

Pediatric Neurology
|June 19, 2014
PubMed

Insights

Extremely low birth weight infants show altered brain metabolite ratios at term-equivalent age. These magnetic resonance spectroscopy (MRS) findings correlate with cognitive and language development at 18-22 months corrected age.

Area of Science:

  • Neuroscience
  • Pediatrics
  • Medical Imaging

Background:

  • Proton magnetic resonance spectroscopy (MRS) is a valuable tool for assessing brain development and integrity.
  • Understanding brain maturation in preterm infants is crucial for predicting long-term outcomes.

Purpose of the Study:

  • To compare cerebral MRS metabolite ratios between extremely low birth weight (ELBW) infants and healthy term controls at term-equivalent age.
  • To investigate the association between MRS metabolites and neurodevelopmental outcomes at 18-22 months corrected age in ELBW infants.

Main Methods:

  • A prospective cohort study involving 43 infants (31 ELBW, 12 controls).
  • Single-voxel point-resolved spectroscopy was used to measure MRS metabolite ratios (NAA/Cho, NAA/mIns) in the hippocampus, cortex, and subventricular zone.
  • Neurodevelopmental assessment using Bayley Scales at 18-22 months corrected age.

Main Results:

  • ELBW infants demonstrated significantly lower NAA/Cho ratios in the subventricular zone and cortex compared to controls.
  • Lower NAA/Cho ratio in the subventricular zone and cortex, and NAA/mIns ratio in the subventricular zone were associated with poorer Bayley mental scores.

Conclusions:

  • Abnormalities in brain metabolite ratios detected by MRS at term-equivalent age are linked to impaired cognitive and language development in ELBW infants.
  • MRS may serve as an early biomarker for neurodevelopmental deficits in high-risk infant populations.
Abstract